PDB29 A COST-UTILITY ANALYSIS OF SODIUM-GLUCOSE COTRANSPORTER (SGLT) 2 INHIBITORS IN ADDITION TO BASAL-BOLUS INSULIN IN THE TREATMENT OF TYPE 1 DIABETES IN THE USA USING THE PRIME DIABETES MODEL
May 1, 2020, 00:00
10.1016/j.jval.2020.04.217
https://www.valueinhealthjournal.com/article/S1098-3015(20)30405-8/fulltext
Title :
PDB29 A COST-UTILITY ANALYSIS OF SODIUM-GLUCOSE COTRANSPORTER (SGLT) 2 INHIBITORS IN ADDITION TO BASAL-BOLUS INSULIN IN THE TREATMENT OF TYPE 1 DIABETES IN THE USA USING THE PRIME DIABETES MODEL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30405-8&doi=10.1016/j.jval.2020.04.217
First page :
Section Title :
Open access? :
No
Section Order :
10074